Circulating TNF-alpha and IL-6 concentrations and TNF-alpha -308 G > A polymorphism in children with premature adrenarche

Frontiers in Endocrinology

Volumn 1, Issue NOV, 2010, Pages

  Utriainen, Pauliina ^a   Jääskeläinen, Jarmo ^a   Gröhn, Oskari ^b   Kuusisto, Johanna ^a   Pulkki, Kari ^b   Voutilainen, Raimo ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Adipose tissue; Birth weight; Body mass index; Gene polymorphism; Interleukin 6; Premature adrenarche; Proinflammatory cytokines; Tumor necrosis factor alpha

Indexed keywords

EID: 84874141603     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2010.00006     Document Type: Article

References (39)

1. Alberti, K. G., Zimmet, P., and Shaw, J. (2006). Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet. Med. 23, 469-480.
2. Andersen, L. B., Müller, K., Eiberg, S., Froberg, K., Andersen, J. F., Bugge, A., Hermansen, B. E-N., and McMurray, R. G. (2010). Cytokines and clustered cardiovascular risk factors in children. Metabolism 59, 561-566.
3. Antuna-Puente, B., Feve, B., Fellahi, S., and Bastard, J. P. (2008). Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab. 34, 2-11.
4. Bastard, J. P., Maachi, M., Van Nhieu, J. T., Jardel, C., Bruckert, E., Grimaldi, A., Robert, J. J., Capeau, J., and Hainque, B. (2002). Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J. Clin. Endocrinol. Metab. 87, 2084-2089.
5. Cao, Y. L., Hu, C. Z., Meng, X., Wang, D. F., and Zhang, J. (2008). Expression of TNF-alpha protein in omental and subcutaneous adipose tissue in obesity. Diabetes Res. Clin. Pract. 79, 214-219.
6. Cole, T. J., Freeman, J. V., and Preece, M. A. (1995). Body mass index reference curves for the UK, 1990. Arch. Dis. Child. 73, 25-29.
7. Dandona, P., Weinstock, R., Thusu, K., Abdel-Rahman, E., Aljada, A., and Wadden, T. (1998). Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J. Clin. Endocrinol. Metab. 83, 2907-2910.
8. Despres, J. P., and Lemieux, I. (2006). Abdominal obesity and metabolic syndrome. Nature 444, 881-887.
9. Escobar-Morreale, H. F., Calvo, R. M., Sancho, J., and San Millan, J. L. (2001). TNF-alpha and hyperandrogenism: a clinical, biochemical, and molecular genetic study. J. Clin. Endocrinol. Metab. 86, 3761-3767.
10. Fernandez-Real, J. M., Gutierrez, C., Ricart, W., Casamitjana, R., Fernandez-Castaner, M., Vendrell, J., Richart, C., and Soler, J. (1997). The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 46, 1468-1472.
11. Fernandez-Real, J. M., Vayreda, M., Richart, C., Gutierrez, C., Broch, M., Vendrell, J., and Ricart, W. (2001). Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J. Clin. Endocrinol. Metab. 86, 1154-1159.
12. Fried, S. K., Bunkin, D. A., and Greenberg, A. S. (1998). Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83, 847-850.
13. Gonzalez, F., Thusu, K., Abdel-Rahman, E., Prabhala, A., Tomani, M., and Dandona, P. (1999). Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome. Metabolism 48, 437-441.
14. Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., and Spiegelman, B. M. (1995). Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95, 2409-2415.
15. Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., and Spiegelman, B. M. (1996). IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesityinduced insulin resistance. Science 271, 665-668.
16. Hotamisligil, G. S., Shargill, N. S., and Spiegelman, B. M. (1993). Adipose expression of tumor necrosis factoralpha: direct role in obesity-linked insulin resistance. Science 259, 87-91.
17. Ibanez, L., Potau, N., Chacon, P., Pascual, C., and Carrascosa, A. (1998). Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia 41, 1057-1063.
18. Ibanez, L., Potau, N., Francois, I., and de Zegher, F. (1998). Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J. Clin. Endocrinol. Metab. 83, 3558-3562.
19. Ibanez, L., Diaz, R., Lopez-Bermejo, A., and Marcos, M. V. (2009). Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism. Rev. Endocr. Metab. Disord. 10, 63-76.
20. Ibanez, L., Dimartino-Nardi, J., Potau, N., and Saenger, P. (2000). Premature adrenarche - normal variant or forerunner of adult disease? Endocr. Rev. 21, 671-696
21. Ibanez, L., Fucci, A., Valls, C., Ong, K., Dunger, D., and de Zegher, F. (2005). Neutrophil count in small-for-gestational age children: contrasting effects of metformin and growth hormone therapy. J. Clin. Endocrinol. Metab. 90, 3435-3439.
22. Ibanez, L., Ong, K., de Zegher, F., Marcos, M. V., del Rio, L., and Dunger, D. B. (2003). Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche. Clin. Endocrinol. (Oxf.) 58, 372-379.
23. Ibanez, L., Potau, N., Virdis, R., Zampolli, M., Terzi, C., Gussinye, M., Carrascosa, A., and Vicens-Calvet, E. (1993). Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J. Clin. Endocrinol. Metab. 76, 1599-1603.
24. Katsuki, A., Sumida, Y., Murashima, S., Murata, K., Takarada, Y., Ito, K., Fujii, M., Tsuchihashi, K., Goto, H., Nakatani, K., and Yano, Y. (1998). Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 83, 859-862.
25. Kern, P. A., Saghizadeh, M., Ong, J. M., Bosch, R. J., Deem, R., and Simsolo, R. B. (1995). The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest. 95, 2111-2119.
26. Kroeger, K. M., Carville, K. S., and Abraham, L. J. (1997). The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol. Immunol. 34, 391-399.
27. Mauras, N., Delgiorno, C., Kollman, C., Bird, K., Morgan, M., Sweeten, S., Balagopal, P., and Damaso, L. (2010). Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. J. Clin. Endocrinol. Metab. 95, 1060-1068.
28. Mathew, R. P., Byrne, D. W., Linton, M. F., Vaughan, D. E., Fazio, S., and Russell, W. E. (2008). Evidence of metabolic syndrome in lean children with premature pubarche at diagnosis. Metabolism 57, 733-740.
29. Nonogaki, K., Fuller, G. M., Fuentes, N. L., Moser, A. H., Staprans, I., Grunfeld, C., and Feingold, K. R. (1995). Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology 136, 2143-2149.
30. Oppenheimer, E., Linder, B., and DiMartino-Nardi, J. (1995). Decreased insulin sensitivity in prepubertal girls with premature adrenarche and acanthosis nigricans. J. Clin. Endocrinol. Metab. 80, 614-618.
31. Paterson, W. F., Ahmed, S. F., Bath, L., Donaldson, M. D. C., Fleming. R., Greene, S. A., Hunter, I., Kelnar, C. J. H., Mayo, A., Schulga, J. S., Shapiro, D., Smail, P. J., and Wallace, A. M. (2010). Exaggerated adrenarche in a cohort of Scottish children: clinical features and biochemistry. Clin. Endocrinol. (Oxf.) 72, 496-501.
32. Pihkala, J., Hakala, T., Voutilainen, P., and Raivio, K. (1989). [Characteristic of recent fetal growth curves in Finland]. Duodecim 105, 1540-1546.
33. Rizvi, A. A. (2009). Cytokine biomarkers, endothelial inflammation, and atherosclerosis in the metabolic syndrome: emerging concepts. Am. J. Med. Sci. 338, 310-318.
34. Utriainen, P., Jääskeläinen, J., Romppanen, J., and Voutilainen, R. (2007). Childhood metabolic syndrome and its components in premature adrenarche. J. Clin. Endocrinol. Metab. 92, 4282-4285.
35. Utriainen, P., Voutilainen, R., and Jääskeläinen, J. (2009). Continuum of phenotypes and sympathoadrenal function in premature adrenarche. Eur. J. Endocrinol. 160,657-665.
36. Utriainen, P., Voutilainen, R., and Jääskeläinen, J. (2009). Girls with premature adrenarche have accelerated early childhood growth. J. Pediatr. 154, 882-887.
37. Voutilainen, R., Perheentupa, J., and Apter, D. (1983). Benign premature adrenarche: clinical features and serum steroid levels. Acta Paediatr. Scand. 72, 707-711.
38. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., and Ferrante, A. W. Jr. (2003). Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808.
39. Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., and Duff, G. W. (1997). Effect of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. U.S.A. 94, 3195-3199.